Watch PMI. Know when insiders buy.
One email the day a filing lands. Free.
PMI
Picard Medical, Inc.
4.62
−0.25 −5.13%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $10.8MP/E —DIV YIELD —FCF YIELD —REV TTM $6.3M +41.0%NET INCOME −$28MNET CASH —52W 3.03 – 660.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $3M | +38.6% | 20.9% | −$4.6M | −$5.7M | — | -3.05 | −$1.4M | $0 | −$1.4M | Aug 19 |
| Q1 2026 · Mar 31 | $1.1M | +85.5% | 23.9% | −$4.5M | −$7.6M | — | -0.10 | −$3.8M | $26K | −$3.8M | Aug 19 |
| Q4 2025 · Dec 31derived | $1M | +20.7% | 40.7% | −$3M | −$4.3M | — | 0.21 | −$4.4M | — | — | Mar 30 |
| Q3 2025 · Sep 30 | $1.2M | +34.7% | -11.0% | −$3.5M | −$10.4M | — | -0.19 | −$6.5M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $2.1M | +207.1% | -6.0% | −$3.5M | −$6.7M | — | -42.39 | −$2.5M | $0 | −$2.5M | Aug 19 |
| Q1 2025 · Mar 31 | $620K | — | -57.7% | −$3.2M | −$5.6M | — | -0.80 | −$2.2M | $0 | −$2.2M | Aug 19 |
| Q4 2024 · Dec 31derived | $836K | — | 16.3% | −$3.6M | −$8.8M | — | -1.20 | −$3.2M | — | — | Mar 30 |
| Q3 2024 · Sep 30 | $881K | — | -76.4% | −$4.4M | −$6.2M | — | -0.87 | −$2.6M | — | — | Nov 14 |
| Q2 2024 · Jun 30 | $694K | — | -55.0% | −$3.8M | −$4.1M | — | — | — | — | — | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | — | −$2M | — | — | — | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $4.9M | -4.1% | −$13.3M | −$27M | -546.6% | -0.75 | −$15.7M | — | — | — | — |
| FY2024 · to Dec 31 | $4.4M | -2.6% | −$13.7M | −$21.1M | -479.5% | -2.99 | −$11.9M | — | — | — | — |
Every number comes from Picard Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.